Sandbox Myopathy: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) |
||
Line 6: | Line 6: | ||
{| class="wikitable" | {| class="wikitable" | ||
! rowspan="3" |Disease | ! rowspan="3" |Disease | ||
! colspan=" | ! colspan="9" |Symptoms | ||
! rowspan="3" |History | ! rowspan="3" |History | ||
! rowspan="3" |Physical | ! rowspan="3" |Physical | ||
Line 13: | Line 13: | ||
|- | |- | ||
! rowspan="2" |Age of onset | ! rowspan="2" |Age of onset | ||
! colspan="2" |Muscle weakness | ! colspan="2" |Muscle weakness | ||
! rowspan="2" |Fever | ! rowspan="2" |Fever | ||
Line 29: | Line 28: | ||
!DIstal | !DIstal | ||
|- | |- | ||
! colspan=" | ! colspan="17" |Medications | ||
|- | |- | ||
|Corticosteroids | |Corticosteroids | ||
| | | | ||
* Variable | * Variable | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 65: | Line 63: | ||
| | | | ||
* 60+ | * 60+ | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 93: | Line 90: | ||
| | | | ||
* Variable | * Variable | ||
| '''+''' | | '''+''' | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 120: | Line 116: | ||
* Normal | * Normal | ||
|- | |- | ||
! colspan=" | ! colspan="17" |Endocrine | ||
|- | |- | ||
|Cushing's disease | |Cushing's disease | ||
| | | | ||
* 25 -45 | * 25 -45 | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 166: | Line 161: | ||
| | | | ||
* 30-50 years | * 30-50 years | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 199: | Line 193: | ||
| | | | ||
* 50 | * 50 | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 228: | Line 221: | ||
| | | | ||
* 40 | * 40 | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 258: | Line 250: | ||
| | | | ||
* >55 | * >55 | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 285: | Line 276: | ||
| | | | ||
* 45 | * 45 | ||
| + | | + | ||
| - | | - | ||
Line 315: | Line 305: | ||
* Normal | * Normal | ||
|- | |- | ||
! colspan=" | ! colspan="17" |Inflammatory / Rheumatologic | ||
|- | |- | ||
|Dermatomyositis<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649 }}</ref> | |Dermatomyositis<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649 }}</ref> | ||
Line 321: | Line 311: | ||
* 40s-50s | * 40s-50s | ||
* Can affect childreen | * Can affect childreen | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| - | | - | ||
Line 352: | Line 341: | ||
| | | | ||
* > 18 years | * > 18 years | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| - | | - | ||
Line 374: | Line 362: | ||
| | | | ||
* 50s | * 50s | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| + | | + | ||
Line 394: | Line 381: | ||
| | | | ||
* 40-50s | * 40-50s | ||
| | | | ||
+ | + | ||
Line 425: | Line 411: | ||
| | | | ||
* 50s | * 50s | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 449: | Line 434: | ||
* Normal | * Normal | ||
|- | |- | ||
! colspan=" | ! colspan="17" |Genetic | ||
|- | |- | ||
|Becker muscular dystrophy | |Becker muscular dystrophy | ||
|<13yrs | |<13yrs | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 478: | Line 462: | ||
|Duchenne muscular dystrophy | |Duchenne muscular dystrophy | ||
|<13 yrs | |<13 yrs | ||
| + | | + | ||
| - | | - | ||
Line 505: | Line 488: | ||
|Limb-girdle muscular dystrophies | |Limb-girdle muscular dystrophies | ||
|<15 yrs | |<15 yrs | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 535: | Line 517: | ||
|- | |- | ||
|Myotonic dystrophy type 1 | |Myotonic dystrophy type 1 | ||
| | | | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 555: | Line 536: | ||
| | | | ||
| | | | ||
| | | colspan="2" | | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="17" |Infectious | ||
|- | |- | ||
|Lyme disease | |Lyme disease | ||
|Variable | |Variable | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 596: | Line 575: | ||
|Infulenza | |Infulenza | ||
|Variable | |Variable | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 625: | Line 603: | ||
|Polio | |Polio | ||
|<5 yrs | |<5 yrs | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 656: | Line 633: | ||
|Syphilis | |Syphilis | ||
|Variable | |Variable | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 690: | Line 666: | ||
|Pyomyositis | |Pyomyositis | ||
|Variable | |Variable | ||
|<nowiki>+/-</nowiki> | |<nowiki>+/-</nowiki> | ||
|<nowiki>+/-</nowiki> | |<nowiki>+/-</nowiki> | ||
Line 717: | Line 692: | ||
* - | * - | ||
|- | |- | ||
! colspan=" | ! colspan="17" |Neurologic | ||
|- | |- | ||
|ALS | |ALS | ||
| | | | ||
| | | | ||
Line 739: | Line 713: | ||
|- | |- | ||
|Stroke | |Stroke | ||
|>65 | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
| | | | ||
* Dysphagia | |||
* Unilateral/Bilateral weakness | |||
| | | | ||
* H/o HTN, dyslipedemia DM | |||
| | | | ||
* Weakness of the involved arm | |||
* | |||
| | | colspan="2" | | ||
| | |||
| | | | ||
| | | | ||
Line 758: | Line 735: | ||
|- | |- | ||
|GBS | |GBS | ||
| | | | ||
| | | | ||
Line 777: | Line 753: | ||
|- | |- | ||
|Multiple Sclerosis | |Multiple Sclerosis | ||
| | | | ||
| | | | ||
Line 795: | Line 770: | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="17" |Neuro-muscular | ||
|- | |- | ||
|Botulisim | |Botulisim | ||
| | | | ||
| | | | ||
Line 817: | Line 791: | ||
|- | |- | ||
|Lambert-Eaton myaes | |Lambert-Eaton myaes | ||
| | | | ||
| | | | ||
Line 836: | Line 809: | ||
|- | |- | ||
|Myasthenia gravis | |Myasthenia gravis | ||
| | | | ||
| | | | ||
Line 854: | Line 826: | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="17" |Paraneoplastic | ||
|- | |- | ||
| | | | ||
| | | | ||
Line 875: | Line 846: | ||
| | | | ||
|- | |- | ||
! colspan=" | ! colspan="17" |Metabolic | ||
|- | |- | ||
|Glycogen storage disease | |Glycogen storage disease | ||
| | | | ||
| | | | ||
Line 897: | Line 867: | ||
|- | |- | ||
|Lipid storage disease | |Lipid storage disease | ||
| | | | ||
| | | | ||
Line 916: | Line 885: | ||
|- | |- | ||
|Mitochondrial | |Mitochondrial | ||
| | | | ||
| | | |
Revision as of 23:02, 3 April 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Differentiating Various Muscle Weakness
Disease | Symptoms | History | Physical
Examination |
Diagnosis | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age of onset | Muscle weakness | Fever | Muscle pain | Gait abnormality | Neuropathy | Myoglobinuria | Other features | Laboratory Findings | Creatine Kinase | Muscle Biopsy | Electromyogram | |||||
Proximal | DIstal | |||||||||||||||
Medications | ||||||||||||||||
Corticosteroids |
|
+ | - | - | + | - | - | - |
|
|
|
|
- | - | - | |
Statins |
|
+ | - | - | + | - | - | -/+(rhabdomyolysis) |
|
|
|
|
|
|
- | |
Alcohol |
|
+ | - | - | - | + | +/- | - |
|
|
|
|
|
|
| |
Endocrine | ||||||||||||||||
Cushing's disease |
|
+ | - | - | - | - | - | - |
|
|
|
|
Normal |
|
Normal | |
Adrenal insufficiency |
|
+ | - | - | - | - | - | - |
|
|
|
|
|
| ||
Hyperaldosteronism with myopathy |
|
+ | + | - | - | - | - | +
Rhabdomyolysis |
|
|
|
|
|
|
| |
Hyperthyroidism |
|
+ | - | - | - | - | - | + |
|
|
|
|
|
|
| |
Hypothyroidism |
|
+ | - | - | + | - | - | + Rhabdomyolysis |
|
|
|
|
|
|
| |
Diabetic infraction |
|
+ | - | + | + | - | + | - |
|
|
|
|
|
|
| |
Inflammatory / Rheumatologic | ||||||||||||||||
Dermatomyositis[1] |
|
+ | - | + | + | - | - | - |
|
|
|
|
| |||
Polymyositis[2] |
|
+ | - | + | + | - | - | - | - | - |
|
|
||||
Inclusion body myositis[3] |
|
+ | + |
|
||||||||||||
Fibomyalgia |
|
+ |
- | - | - | - | ++ | - |
|
|
|
|
|
|
| |
Polymyalgia Rheumatica[4] |
|
+ | - | + | + | - | - | - |
|
|
|
|
|
|
| |
Genetic | ||||||||||||||||
Becker muscular dystrophy | <13yrs | + | - | - | - | + | - | - |
|
|
|
|
| |||
Duchenne muscular dystrophy | <13 yrs | + | - | - | - | + | - | - |
|
|
|
| ||||
Limb-girdle muscular dystrophies | <15 yrs | + | - | - | + | + | - | - |
|
|
|
|
|
|
||
Myotonic dystrophy type 1 | + | + | - | - | + | - | - |
|
||||||||
Infectious | ||||||||||||||||
Lyme disease | Variable | + | - | + | + | +/- | + | - |
|
|
|
|
|
|
| |
Infulenza | Variable | - | - | + | + | + | - | + |
|
|
|
|
|
|
| |
Polio | <5 yrs | + | - | - | - | + | + | - |
|
|
|
|
|
| ||
Syphilis | Variable | - | - | - | - | + | + | - |
|
|
|
|
|
|
| |
Pyomyositis | Variable | +/- | +/- | + | + | - | - | - |
|
|
|
|
|
|
| |
Neurologic | ||||||||||||||||
ALS | ||||||||||||||||
Stroke | >65 | + | + | - | - | + | + | - |
|
|
|
|||||
GBS | ||||||||||||||||
Multiple Sclerosis | ||||||||||||||||
Neuro-muscular | ||||||||||||||||
Botulisim | ||||||||||||||||
Lambert-Eaton myaes | ||||||||||||||||
Myasthenia gravis | ||||||||||||||||
Paraneoplastic | ||||||||||||||||
Metabolic | ||||||||||||||||
Glycogen storage disease | ||||||||||||||||
Lipid storage disease | ||||||||||||||||
Mitochondrial |
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
- ↑ Myklebust G, Gran JT (1996). "A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis". Br J Rheumatol. 35 (11): 1161–8. PMID 8948307.